Cargando…

Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller

HIV-1 controllers are patients who control HIV-1 viral replication without antiretroviral therapy. Control is achieved very early in the course of infection, but the mechanisms through which viral replication is restricted are not fully understood. We describe a patient who presented with acute HIV-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walker-Sperling, Victoria E., Pohlmeyer, Christopher W., Veenhuis, Rebecca T., May, Megan, Luna, Krystle A., Kirkpatrick, Allison R., Laeyendecker, Oliver, Cox, Andrea L., Carrington, Mary, Bailey, Justin R., Arduino, Roberto C., Blankson, Joel N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474502/ https://www.ncbi.nlm.nih.gov/pubmed/28159573 http://dx.doi.org/10.1016/j.ebiom.2017.01.034

Ejemplares similares

A CD3/CD28 microbead-based HIV-1 viral outgrowth assay
por: Kuzmichev, Yury V, et al.
Publicado: (2017)

Combined Effects of HLA-B*57/5801 Elite Suppressor CD8+ T Cells and NK Cells on HIV-1 Replication
por: May, Megan E., et al.
Publicado: (2020)

The Effect of Latency Reversal Agents on Primary CD8 + T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication
por: Walker-Sperling, Victoria E., et al.
Publicado: (2016)

Virovore: A Breakthrough in Virology
por: Sultana, Qamar, et al.
Publicado: (2023)

Does B Cell Follicle Exclusion of CD8+ T Cells Make Lymph Nodes Sanctuaries of HIV Replication?
por: Beck, Sarah E., et al.
Publicado: (2019)

A Human Immunodeficiency Virus Controller With a Large Population of CD4(+)CD8(+) Double-Positive T Cells
por: Durand, Christine M., et al.
Publicado: (2015)

CD8(+) T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants
por: Pohlmeyer, Christopher W, et al.
Publicado: (2013)

CD8 Effector T Cells Function Synergistically With Broadly Neutralizing Antibodies to Enhance Suppression of HIV Infection
por: Veenhuis, Rebecca T., et al.
Publicado: (2021)

Proviral Quasispecies Diversity Is Not Associated With Virologic Breakthrough or CD4(+) T Cell Loss in HIV-1 Elite Controllers
por: de Azevedo, Suwellen S. D., et al.
Publicado: (2019)

Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection
por: Wendel, Sarah K., et al.
Publicado: (2013)

Virologic response and breakthrough in chronic hepatitis B Egyptian patients receiving lamivudine therapy
por: Ismail, Sohair, et al.
Publicado: (2014)

Hantavirus Replication Cycle—An Updated Structural Virology Perspective
por: Meier, Kristina, et al.
Publicado: (2021)

Virology and infection control
por: Valenti, William M.
Publicado: (1984)

SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge
por: Woldemeskel, Bezawit A., et al.
Publicado: (2022)

Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections
por: Karaba, Andrew H, et al.
Publicado: (2022)

Advances and Breakthroughs in IRES-Directed Translation and Replication of Picornaviruses
por: Abdullah, Sahibzada Waheed, et al.
Publicado: (2023)

Controlled Nucleosynthesis: Breakthroughs in Experiment and Theory
por: Adamenko, Stanislav, et al.
Publicado: (2007)

Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir
por: Suzuki, Fumitaka, et al.
Publicado: (2014)

Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B
por: Huang, Yi-Jie, et al.
Publicado: (2019)

HIV-1 DNA predicts disease progression and post-treatment virological control
por: Williams, James P, et al.
Publicado: (2014)

Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy
por: Orrell, Catherine, et al.
Publicado: (2011)

HIV post-treatment controllers have distinct immunological and virological features
por: Etemad, Behzad, et al.
Publicado: (2023)

On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B
por: Huang, Yi-Jie, et al.
Publicado: (2017)

Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy
por: Salgado, Maria, et al.
Publicado: (2011)

Virology, Epidemiology, Pathogenesis, and Control of COVID-19
por: Jin, Yuefei, et al.
Publicado: (2020)

AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection
por: Aksyuk, Anastasia A., et al.
Publicado: (2022)

Evaluation of the dynamic pattern of viral evolution in patients with virological breakthrough during treatment with nucleoside/nucleotide analogs by ultra-deep pyrosequencing
por: CHEN, SHAOLONG, et al.
Publicado: (2016)

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
por: Chia, Po Ying, et al.
Publicado: (2022)

Applications of Replicating-Competent Reporter-Expressing Viruses in Diagnostic and Molecular Virology
por: Li, Yongfeng, et al.
Publicado: (2016)

Treatment of chronic HBV hepatitis – between immune control and virological control
por: Popescu, Cristina, et al.
Publicado: (2014)

Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers
por: Gonzalo-Gil, Elena, et al.
Publicado: (2017)

1529 Raltegravir Plus Tenofovir DF and Emtricitabine for Non-occupational Postexposure Prophylaxis (nPEP): African-Americans are at Higher Risk of Non-Completion of nPEP
por: Vigil, Karen J., et al.
Publicado: (2014)

Breakthrough pain in patients with controlled or uncontrolled pain: An observational study
por: Gatti, Antonio, et al.
Publicado: (2014)

Host Factors Dictate Control of Viral Replication in two HIV-1 Controller/Chronic Progressor Transmission Pairs
por: Buckheit, Robert W., et al.
Publicado: (2012)

Breakthrough!
por: KURNIT, Paul
Publicado: (2010)

Outbreak Breakthrough: Using Whole-Genome Sequencing to Control Hospital Infection
por: Arnold, Carrie
Publicado: (2015)

2487. Low Rate of Virologic Failure in Antiretroviral Experienced Patients Prescribed Once Daily Raltegravir
por: Hsu, Ricky, et al.
Publicado: (2019)

Virological, Immune and Host genetics Markers in the Control of HIV Infection
por: Mothe, Beatriz, et al.
Publicado: (2009)

M-II Quality control in a molecular virology laboratory
por: Niesters, H.G.M.
Publicado: (2009)

Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
por: Gomes, Samara Tatielle M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jcjirq40rtpqp4cetcfr87qq1a